Shayne N. Freemantle

1.0k total citations
22 papers, 778 citations indexed

About

Shayne N. Freemantle is a scholar working on Pharmacology, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shayne N. Freemantle has authored 22 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shayne N. Freemantle's work include Schizophrenia research and treatment (6 papers), Treatment of Major Depression (5 papers) and Pharmacovigilance and Adverse Drug Reactions (4 papers). Shayne N. Freemantle is often cited by papers focused on Schizophrenia research and treatment (6 papers), Treatment of Major Depression (5 papers) and Pharmacovigilance and Adverse Drug Reactions (4 papers). Shayne N. Freemantle collaborates with scholars based in United Kingdom. Shayne N. Freemantle's co-authors include Ronald D. Mann, Richard M. Martin, Gillian Pearce, F. J. Mackay, Nicholas Dunn, Pipasha Biswas, G. L. Pearce, L. V. Wilton, Lynda V. Wilton and Lynda Wilton and has published in prestigious journals such as Thorax, Epilepsia and British Journal of Clinical Pharmacology.

In The Last Decade

Shayne N. Freemantle

22 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shayne N. Freemantle United Kingdom	14	212	170	144	98	95	22	778
Alan D. Dean United States	18	208 1.0×	112 0.7×	214 1.5×	99 1.0×	30 0.3×	23	867
Paul B. van den Berg Netherlands	19	219 1.0×	291 1.7×	81 0.6×	66 0.7×	29 0.3×	43	981
Paul Farquhar-Smith United Kingdom	15	80 0.4×	156 0.9×	190 1.3×	31 0.3×	23 0.2×	35	1.1k
Gillian C. Hall United Kingdom	20	357 1.7×	312 1.8×	157 1.1×	97 1.0×	44 0.5×	48	1.8k
Hannu Allonen Finland	21	157 0.7×	293 1.7×	105 0.7×	137 1.4×	17 0.2×	64	1.5k
Lee L. Lanza United States	12	361 1.7×	35 0.2×	146 1.0×	210 2.1×	28 0.3×	17	1.1k
Diego Macías Saint-Gerons Spain	14	303 1.4×	48 0.3×	45 0.3×	107 1.1×	33 0.3×	46	751
Niklas Schmedt Germany	16	168 0.8×	81 0.5×	44 0.3×	63 0.6×	16 0.2×	43	691
Kent H. Summers United States	17	100 0.5×	62 0.4×	99 0.7×	45 0.5×	9 0.1×	49	1.0k
Jamie N. Brown United States	19	92 0.4×	54 0.3×	50 0.3×	72 0.7×	11 0.1×	69	911

Countries citing papers authored by Shayne N. Freemantle

Since Specialization

Citations

This map shows the geographic impact of Shayne N. Freemantle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shayne N. Freemantle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shayne N. Freemantle more than expected).

Fields of papers citing papers by Shayne N. Freemantle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shayne N. Freemantle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shayne N. Freemantle. The network helps show where Shayne N. Freemantle may publish in the future.

Co-authorship network of co-authors of Shayne N. Freemantle

This figure shows the co-authorship network connecting the top 25 collaborators of Shayne N. Freemantle. A scholar is included among the top collaborators of Shayne N. Freemantle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shayne N. Freemantle. Shayne N. Freemantle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Biswas, Pipasha, Lynda V. Wilton, Gillian Pearce, Shayne N. Freemantle, & Saad Shakir. (2001). The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. Journal of Psychopharmacology. 15(4). 265–271. 48 indexed citations

2.

Biswas, Pipasha, Lynda Wilton, G. L. Pearce, et al.. (2001). Pharmacosurveillance and safety of the leukotriene receptor antagonist (LTRA), montelukast. 1(3). 300–304. 5 indexed citations

3.

Mann, Ronald D., Pipasha Biswas, Shayne N. Freemantle, G. L. Pearce, & Lynda Wilton. (2000). The pharmacovigilance of tamsulosin: event data on 12 484 patients. British Journal of Urology. 85(4). 446–450. 24 indexed citations

4.

Martin, Richard M., et al.. (2000). The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. British Journal of Clinical Pharmacology. 50(4). 366–372. 75 indexed citations

5.

Mackay, F. J., G. L. Pearce, Shayne N. Freemantle, & Ronald D. Mann. (1999). Nefazodone in community use: the results of prescription-event monitoring. Pharmacoepidemiology and Drug Safety. 8(4). 267–273. 4 indexed citations

6.

Freemantle, Shayne N., et al.. (1999). Nicorandil and diabetes: a nested case-control study to examine a signal generated by prescription-event monitoring. European Journal of Clinical Pharmacology. 55(2). 159–162. 3 indexed citations

7.

Freemantle, Shayne N., et al.. (1999). Safety profile of nicorandil—prescription-event monitoring (PEM) study. Pharmacoepidemiology and Drug Safety. 8(3). 197–205. 29 indexed citations

8.

Dunn, Nicholas, Shayne N. Freemantle, & Ronald D. Mann. (1999). Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression. British Journal of Clinical Pharmacology. 48(2). 230–233. 13 indexed citations

9.

Mackay, F. J., et al.. (1999). Losartan: a study of pharmacovigilance data on 14 522 patients. Journal of Human Hypertension. 13(8). 551–557. 19 indexed citations

10.

Wilton, Lynda V., Shayne N. Freemantle, Richard M. Martin, & Ronald D. Mann. (1998). Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?. Pharmacoepidemiology and Drug Safety. 7(S1). S4–S10. 2 indexed citations

11.

Mackay, F. J., L. V. Wilton, G. L. Pearce, Shayne N. Freemantle, & Ronald D. Mann. (1998). United Kingdom experience with alendronate and oesophageal reactions.. PubMed. 48(429). 1161–2. 22 indexed citations

12.

Martin, Richard M., Pipasha Biswas, Shayne N. Freemantle, Gillian Pearce, & Ronald D. Mann. (1998). Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. British Journal of Clinical Pharmacology. 46(5). 505–511. 150 indexed citations

13.

Wilton, Lynda V., Shayne N. Freemantle, Richard M. Martin, & Ronald D. Mann. (1998). Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?. Pharmacoepidemiology and Drug Safety. 7(S1). S4–S10. 6 indexed citations

14.

Martin, Richard M., N. Ray Dunn, Shayne N. Freemantle, & Ronald D. Mann. (1998). Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists. Thorax. 53(7). 558–562. 52 indexed citations

15.

Dunn, Nicholas, Ian R. White, Shayne N. Freemantle, & Ronald D. Mann. (1998). The role of prescribing and referral bias in studies of the association between third generation oral contraceptives and increased risk of thromboembolism. Pharmacoepidemiology and Drug Safety. 7(1). 3–14. 10 indexed citations

16.

Dunn, Nicholas, Ian R. White, Shayne N. Freemantle, & Ronald J. Mann. (1998). The role of prescribing and referral bias in studies of the association between third generation oral contraceptives and increased risk of thromboembolism. Pharmacoepidemiology and Drug Safety. 7(1). 3–14. 1 indexed citations

17.

Mackay, F. J., Nicholas Dunn, Lynda V. Wilton, et al.. (1997). A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiology and Drug Safety. 6(4). 235–246. 74 indexed citations

18.

Mackay, F. J., et al.. (1997). Safety of Long‐Term Lamotrigine in Epilepsy. Epilepsia. 38(8). 881–886. 112 indexed citations

19.

Mackay, F. J., Nicholas Dunn, Lynda V. Wilton, et al.. (1997). A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiology and Drug Safety. 6(4). 235–246. 5 indexed citations

20.

Wilton, Lynda, et al.. (1996). The safety of finasteride used in benign prostatic hypertrophy: a non‐interventional observational cohort study in 14 772 patients. British Journal of Urology. 78(3). 379–384. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact